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INTRODUCTION 
 
“The snake with its many unique and, in some ways 
contradictory attributes has been worshipped, feared, puzzled over, 
hated, loved, exploited, exterminated, studied and even petted. It has 
been used in magic, witchcraft, religion, medicine, war, torture, sports, 
science, commerce and entertainment. On the one hand, it has been a 
symbol of procreation, health, longevity, immortaling, and wisdom, on 
the other; it has represented death, disease, sin, lechery, duplicity, and 
temptation. It is a paradox… Mankind has seldom ignored it”. 
- Ramona & Desmond Morris 
(Men & Snakes) 
 Snake bite is a major public health problem throughout the 
world especially in tropical and subtropical countries. Snake venom is 
probably the oldest known poison to mankind and has been described 
in old medical writings and myths. Frayer in his study of 
Thanatophidia of India estimated that about 1 in 10,000 population 
died due to snake bite.1 
 Snakes have formed an object of awe and curiosity at all levels. 
They have been associated with mysticism apart from being objects of 
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fear. Venomous snake bites account for much of the morbidity and 
mortality world wide. Venomous snakes are estimated to inflict 4 lakh 
bites annually and approximately 40,000 of these victims die. The 
actual numbers are much larger, as in India itself it was calculated to 
be 2, 00,000 bites annually.2 
 In India snake bite is an occupational hazard of farmers in rural 
area and an estimated 15,000 to 20,000 people die each year from 
snake bite. The high mortality in India is due to climatic factors, rural 
predominance of population and their agricultural dependence. 
 Of the more than 2,700 species of snakes, about 500 belong to 
the four families of venomous snakes and only 200 species have 
caused morbidity in humans. India has always been known as the land 
of exotic snakes.  
In India there are about 216 species of snakes of which about 52 are 
venomous and of these, only 5 varieties of snakes are commonly 
encountered as the cause of snake bite poisoning.3 They are 
 Russell’s viper - Doboia ruselli 
 Cobras  - (Common cobra – Naja Naja) 
 Krait    - Bungarus Caeruleus 
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 Saw scaled viper - Echis Curinatus 
-      Pit Viper4 
Based on their morphological characteristics including 
arrangement of scales, dentition, sensory organs etc. snakes are 
categorized into families. The families of venomous snakes are : 
1) Atractaspididae  2) Elapidae  3) Hydrophidae and  4) Viperidae. 
Viperidae group causes hemorrhagic syndrome. Elapidae group causes 
neuromuscular paralysis leading to flaccid paralysis and death by 
respiratory failure. 
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REVIEW OF LITERATURE 
The word ‘snake’ is derived from the Anglo-Saxon word 
“Snaca” meaning “creeping5”.  
Nearly 240 million years ago there were fifteen orders of these 
reptiles and now only five have survived. Ophidians are the creeping 
animals commonly known as snakes.6 
Dr. Patrick Russel7 the “Father of Indian Ophiology” gave the 
earliest reference to Indian Snakes. The credit for distinguishing the 
venomous from the non-venomous snakes goes to him. It was he who 
focused attention on the viper Vipera Russelli, which was 
appropriately named after him. 
Sir J.B.Fayrer8 (1873) was a physician cum surgeon who turned 
to an ophiologist. He had carried out detailed investigations on the 
physiology of venom of Indian snakes. He wrote a book entitled 
“Thanatophidia of India” in 1874. Joseph Ewarts9, (1878) book on the 
poisonous snakes of India was also an invaluable publication. 
Several medical personnel have conducted investigations on the 
venomous snakes of India and the properties of their venom. The list of 
such workers is long and exhaustive, nevertheless, mention should be 
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made of the pioneering work carried out in recent times by Ahuja and 
Gurkripal Singh10 (1954). Deoraj11 (1963-1971) and Whitaker12 (1978), 
Daniel13 (1983) have given detailed facts and figures about the venom 
of the common venomous snakes. Murthy14 (1985) has discussed the 
common venomous snakes of India and has also given an account of 
these snakes for the benefit of the layman. 
Detailed information on the clinical aspects of snake bites in 
India and Southeast Asia has been given by Alistair Reid H15 (1963) 
Likewise, Banerjee RN and Siddiqui ZA16 (1974) OF Safdarjung 
Hospital, New Delhi conducted a micro study of snake bites, which 
includes every aspect of envenomation. Sawai et al17 (1974) of Japan 
Snake Institute published a statistical data on snakebite and historical 
records of the patients from different states in India during his visit to 
India from October to December 1972. 
The review of the progress of snake venom research in India will 
be incomplete without paying tributes to the services rendered by three 
famous institutes namely, the Haffkine Institute, Mumbai, for Training, 
Research & Testing, The Madras Snake Park, The Calcutta Snake Part 
and the Central Research Institute, Kasauli which served as catalysts 
for the dissemination of knowledge related to venomous snakes of 
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India and their venom, preparation of anti snake venom sera and the 
treatment of snake bites. 
Subhadeep Sarkar, Parthasaratho Mitra and Kunal Bhattacharya 
observed that Russel’s viper is responsible for 60 percent of the deaths 
from snakebite that occurs in India every year. Death following snake 
bite is the cumulative effect of all the toxic reactions that venoms 
produce in the body of the victim. They say we are looking at just one 
aspect18.  Manjunath B et al reported a case of snakebite, where a 
young boy succumbed to death due to delay in hospitalization owing to 
the lack of awareness.19 
Snake bite global scenario20 
Since reporting is not mandatory in many regions of the world20, 
snakebites often go unreported. Consequently, no accurate study has 
ever been conducted to determine the frequency of snakebites on the 
international level. However, some estimates put the number at 5.4 
million snakebites, 2.5 million envenomation, resulting in perhaps 
1,25,000 deaths. Others estimate 1.2 to 5.5 million snakebites, 421,000 
to 1.8million envenomation, and 20,000 to 94,000 deaths. Many people 
who survive bites nevertheless suffer from permanent tissue damage 
caused by the venom, leading to disability.21 
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Indian Scenario 
 Indian subcontinent, being tropical, harbors a variety of 
venomous and non-venomous snakes. The major families of snakes in 
India are Elapidae, Viperidae and Hydrophidae (Bawaskar, 2004). The 
four major venomous biting species “The BIG FOUR” are Cobra (Naja 
Naja), Krait (Bungarus Caeruleus), Russell’s viper (Vipera russelli), 
and Saw – scaled viper (Echis carinatus). The former two belong to the 
Elapidae and the latter two belong to the Viperidae family22. Based on 
an epidemiological field survey of 26 villages with a total population 
of nearly 19,000 individuals in Burdwan district of West Bengal state 
in India, Hati et al worked out an annual incidence of 0.16% and 
mortality rate of 0.016% per year23. Maharashtra, one of the states in 
India, with the highest incidence of snake bites reported, 70 bites per  
1, 00,000 population and mortality of 2.4 per 1,00,000 per year24. The 
commonest cause of snake bite envenomation in Jammu was Viperine 
Snake bite, accounting for 310 cases in years 1968 to 197125. The other 
states with a large number of snake bite cases include West Bengal, 
Tamil Nadu, Uttar Pradesh and Kerala26.  
Swaroop reported about 2, 00,000 bites and 15,000 deaths in India due 
to snake bite envenomation as far back as 195427.  In Sri Lanka the 
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overall annual mortality from a single venomous species ranges from 
5.6 per 1, 00,000 to as high as 18 per 1, 00,000 in some areas28. It has 
been estimated that 150 to 200 snake bite related deaths occur annually 
in Nepalese hospitals29. It has been reported that in most developing 
countries up to 80% of individuals bitten by a snake, first consult 
traditional practitioners before visiting a medical centre and owing to 
the delay, several victims die during transit to the hospital30. 
Host Factor 
 Among the host factors, people involved in occupations and or 
life style requiring movement in dense undergrowth or undeveloped 
land, are the worst affected. These include farmers, herders, hunters 
and workers on development sites31. 
Snake bite has been observed in all age groups. But majority 
(90%) are males and aged between 11-50 years. Paul reported an 
incidence of 7.15% in children less than 10 years.32 Another study 
reported 37% incidence in the second decade of life.33 The sex ratio 
seems almost uniform all over, with males being affected twice or 
thrice commoner than females. The preponderance of male victims 
suggests a special risk of outdoor activity. For obvious reasons, bite is 
maximal in lower limbs with 40% occurring in feet alone.34 
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Causative Factor 
 One or the other species of this reptile is seen in almost all the 
countries of the world. The dangerous ones are prevalent in tropical 
and subtropical countries, but they are not seen over 3,000 feet above 
sea level. Snakes are not found in extremely cold climate. The majority 
of them are harmless to humans in temperate climate. In England, for 
example, there were only 14 deaths due to snake bite in the past 100 
years (Warrell).35 
 There are a few countries in the world that do not seem to harbor 
them and these are Madagascar, New Zealand, Azores, Canary Islands, 
Haiti, Puerto Rico, Ireland and Iceland. 
 Every state in India, Pakistan and Bangladesh has poisonous 
snakes. They are particularly a source of great danger in the low lying 
areas along the great rivers. The experience of Bhat in Jammu Kashmir 
in treating snake bite envenomation in the very north and that of ours 
in the very south was different by the fact that in our patient’s mortality 
and morbidity were considerably higher. The cold climatic conditions 
of Jammu Kashmir probably account for this favourable outcome in 
the north. 
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Morbidity and mortality resulting from snake bite envenomation 
also depends on the species of snake involved, since the estimated 
“fatal dose” of venom varies with the species. In the Indian setting 
almost 2/3 of bites are attributed to Saw scaled viper (as high as 95% 
in some areas like Jammu), 36 and about ¼ to Russell’s viper and 
smaller proportions to Cobra and Kraits37. In Srilanka, Doboia russelli 
accounts for 40% of bites and Naja Naja for another 35%38 , Daboisa 
russelli alone accounts for 70% of bites in Myanmar. Among the 
various species, the average yield of venom per bite in terms of dry 
weight of lyophilized venom is  
60 mg for Cobras 
63 mg for Russell’s viper 
20 mg for Krait and  
13 mg for Saw scaled viper 
 
 The respective fatal doses are much smaller viz. 12mg, 15mg, 
6mg and 8mg91. However, clinical features and outcome are not as 
simple to predict because every bite does not result in complete 
envenomation92. 
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Environmental Factors 
Nearly 75% cases of snake bite are encountered in out door areas 
with a rural incidence ranging from 75-90%. Snake bites are common 
during day time in South India, contrary to high incidence of nocturnal 
bites in few parts of North India. 
Snake activity is least in winter season when incidence of bites 
is at its lowest.  Rainy season is the period of activity for snakes, when 
busy agricultural work coincidentally doubles the risk. Few studies 
show a distinct seasonal pattern39 with a peak in warm and rainy 
months which compel the reptiles to come out of their shelter. 
Snakes are predominantly nocturnal in habit. Nocturnal bites of 
any snake are likely to be more venomous than bites by day time. This 
higher night time envenomation may be due to their clearer vision at 
night. Some of the poisonous snakes are very timid, shy and docile in 
morning hours, and enter the bed of humans probably due to 
thermophilic factors and inflict spontaneous bites. One of the problems 
with nocturnal bite is the difficulty in identification of the snake 
species. 
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Irritable species that strike readily when disturbed include E. 
Carinatus, makyan pit-viper, most species of rattle snakes, lance 
headed viper and cobras. 
Snakes 
 Snakes are reptiles which belong to the order ophidian. Fewer 
that one tenth of the nearly 3000 known species of snakes are 
venomous. The poisonous varieties belong to five families. 40 
a. Elapidae  - Cobras, Kraits and Coral snakes  
(found all over the world except Europe) 
b. Viperidae  - Russell’s viper, saw scaled viper  
(Found all over the world except America). 
c. Hydrophidae - Sea snakes 
d. Crotolidae - Pit vipers (found in Asia and America) 
e. Colubridae - Bird Snake (found commonly in Africa) 
 
Characteristics of Snakes 
 They have got an elongated body divided into head, body and 
tail. There are no external appendages except some rudimentary 
structures seen in some non-poisonous varieties like Typholps. The 
body of snake is covered by scales which are imbricate in primitive 
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snakes and form a distinctive covering in other snakes. Special scales 
are developed on the head and helps in identifying different snakes. 
Exuvia is formed over the scales periodically and sloughed off by the 
snake periodically. The snakes grow throughout its life. There are 
around 200-300 vertebrae in the snakes and all except for the first two 
and the tail, have ribs. 
 The snakes have eyes with vertical pupil but no eye lids. They 
have a pair of primitive internal ears without external appendages.41 
 The lower jaw in the snakes is a pair of bones connected 
centrally in front by a firm elastic ligament and it does not articulate 
with the maxilla as in mammals. 
 The snakes have a row of teeth on either side of the premaxilla 
and the mandible. In poisonous varieties there are modified teeth, 
usually two in number and occasionally more than one pair, called 
fangs, which are present on the premaxilla and not on the mandible. 
The fangs have channels for pouring the venom either in the form of 
gutter, as in cobras or hollow with a tiny opening at the pointed end 
like a hypodermic needle, as seen in Russell’s viper. At the base of the 
fangs opens the duct of the poison gland one on either side of the jaw 
below the orbit. Anteriorly the gland opens into a narrow venomous 
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duct which ends in an ampulla like dilatation at the base of the fangs. 
Snakes are provided with an alimentary digestive system, respiratory 
system, urogenital system, circulatory and central nervous system. 
Habitat of snakes41 
 Snakes are cold blooded animals as they do not have an efficient 
thermo regulating organ, except for certain species like saw scaled 
viper (Echis carnatus). Snakes prefer a tolerable amount of humidity, 
darkness and quietness. Snakes live mainly on insects, smaller snakes, 
frogs, lizards, mice and rats. The range of vision in snakes is limited 
and is mainly confined to a very close range and is more active on the 
moving objects in the immediate vicinity. 
Classification 
 Snakes are broadly classified into two groups. Poisonous and 
non poisonous. The poisonous snakes are further classified on the basis 
of poison secreted by them into 3 main types. 
1. Neurotoxic – Secreting Neurotoxic venom (Elapids) 
2. Vasculotoxic – Secreting Vasculotoxic venom (Viper) 
3. Myotoxic (Sea Snakes) 
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The differentiating features of poisonous and non poisonous 
snakes’ are42 
 
TABLE1 : POISONOUS AND NON POISONOUS SNAKE BITES  
NO. FEATURES POISONOUS NONPOISONOUS 
1 Belly scales 
seen by 
turning the 
snake with 
belly upwards 
Large and cover width of the belly.  Small like those on 
the back or 
moderately large but 
they do not cover the 
entire breadth.  
2 Head scales Small (viper) or may be large and wide  Large with exception 
of pit viper, cobra 
and Krait. 
3 Fangs Two long grooved or canalized fangs like 
hypodermic needles. 
Multiple, short and 
solid teeth. 
4. Tail Compressed Not much 
compressed 
5 Habits Usually nocturnal Not so 
6 Bite mark Two fang marks with or without small 
mark of other teeth 
A number of small 
teeth marks in a row. 
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TABLE 2: COMMON POISONOUS SNAKES IN INDIA 
(WHITAKER 1978) 
 
Name Distinctive 
Features 
Average Length Distribution Habitat Common 
Prey 
Type of 
Toxicity 
Indian 
Cobra 
(Naja Naja) 
Medium 
size to 
large, 
smooth, 
shiny 
scales 
1m, At birth 25cm 
male 2m 
Throughout 
India sea 
level upto 
4000m 
Common 
in Rice 
growing 
Areas 
Small 
Snakes, 
Insects, 
Lizards. 
Neurotoxic 
Common 
Krait 
(Bungarus 
Caeruleus) 
Medium 
sized, 
smooth, 
glossy 
scales 
1m, At birth 
25cm, male 1.75m
Most of 
India Sea 
level up to 
1700m 
Sandy soil, 
Termite 
mounds 
Piles of 
brick 
Mainly 
snakes 
Lizards & 
rodents 
Neurotoxic  
Russell’s 
viper 
(Vipera 
russelli) 
Medium 
size to 
Large, 
strongly 
keeled 
scales 
1m, At birth 24cm 
male 1.8m 
Hills & 
Plains of 
India. Sea 
level up to 
3000m 
Common 
in houses 
present in 
hill areas 
Snakes, 
Lizards, 
Mice, 
Land crabs 
Hemorrhagic
Saw-scaled 
viper 
(Echis 
Carinnatus) 
Small, 
Strongly 
keeled 
scales, dull 
colour 
South India: 30cm 
North India: 50cm 
At birth : 8cm, 
Max.80cm 
Throughout 
India, 
mostly 
plains, upto 
2000m 
above sea 
level and in 
hills. 
Not found 
in the 
heavily 
forested 
areas  and 
hills 
Mice, 
Lizard, 
Frogs 
Hemorrhagic
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Snakes of Medical Importance in Tamil Nadu – Distinguishing 
features43  
A great deal is written concerning the problem of how to identify 
medically significant species from non significant ones. A large 
amount of space is devoted, in both medical and toxicology textbooks, 
to the problem of how to identify venomous snakes. The problem with 
this information is that it is complex (involves counting of scales) and 
not definitive (the identification of pre or post maxillary teeth) and of 
no use to a doctor in a medical situation. On the question of 
description, it is worth remembering that the least reliable means of 
identifying a particular species of snake is to use color. Virtually every 
species of venomous snakes have a huge range of color manifestations 
and even the markings can be subject to major variations. What is 
important therefore is to focus on the key aspects of identification that 
enable the medical professional to rapidly identify whether they are 
dealing with a venomous species, and what that species might be. 
 
There are six medically important species in Tamil Nadu shown 
in Fig.3. 
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Russell ’s viper (Daboia russelii) 
The Russell’s viper is a stout bodied snake, the largest of which 
grows to approximately 1.8 meters in length. Like all the vipers it is a 
nocturnal snake, but unfortunately for humans, during the daytime it 
rests up under bushes, at the base of trees and in leaf litter. It is 
therefore frequently encountered by rural workers, as they are carrying 
out general agricultural activities. 
 
There are two key identification features that are worth noting. 
The first is a series of chain-like or black edged almond shaped marks 
along the snakes back and flanks. The second distinguishing mark is a 
white triangular mark on the head with the apex of the triangle pointing 
towards the nostrils. 
Saw scaled Viper (Echis carinatus) 
The southern Indian Saw Scaled Viper is a small snake, usually 
between 30 and 40 cm long. The northern Indian species (Echis 
sochureki) is much larger, with an average size of 60 cm. It inhabits 
mainly dry arid climates but can also be found in scrubland. 
One of the key identification features of this species is the 
posture it adopts when it is agitated. It moves its body into a figure of 
eight like arrangement with its head at the centre. It rapidly moves its 
coils against each other and produces a hissing like sound which gives 
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its name ‘Saw Scaled’. In addition, there are often wavy hoop like 
markings down both sides of the Saw Scales body. On the head, there 
is usually a white or cream arrow shaped mark, pointing towards the 
front of the head, often compared to the shape of a bird’s foot. 
The Hump-nosed Pit viper (Hypnale hypnale) 
The Hump-nosed pit viper is one of India’s tiniest venomous 
snakes, its total length ranging from 28.5 to 55cm. Its distinctive 
features include the presence of five large symmetrical plate scales on 
the top of the head in addition to the smaller scales typical of all vipers. 
There are heat sensitive pits between the nostril and the eye. 
Spectacled Cobra (Naja naja) 
The Spectacled Cobra is probably India’s most well recognized snake. 
The hood markings of the spectacle like mark, distinguishes this snake 
from other species, and its habit of rearing up when alarmed makes it 
distinctive but not definitive as other species do this, notably the 
Trinket Snake. The Cobras coloration may vary from pale yellow to 
black. 
Common Krait (Bungarus caeruleus) 
The Common Krait is a nocturnal snake which usually grows to 
approximately 1.0 to 1.2 meters in length. Its primary diet is other 
snakes. It can be found all over Peninsular India and often seeks 
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habitation near human dwellings. During the day it rests up in piles of 
bricks, rat burrows or other buildings. The Common Krait is the most 
poisonous snake in India and its venom is pre-synaptic neurotoxic in 
nature. 
There are a number of key identifiers which are worth 
remembering. The Krait is black, sometimes with a bluish tinge, with a 
white belly. Its markings consist of paired white bands which may be 
less distinct anteriorly. These paired white bands distinguish the snake 
from another black nocturnal snake, the Common Wolf Snake.  
The Wolf Snake’s white bands usually are thicker and are 
singular bands equidistant from each other. The second useful 
distinguishing feature is a series of hexagonal scales along the top of 
the snakes back. This feature is really useful if the dead snake has been 
brought to the hospital and examined. 
King Cobra (Ophiophagus hannah) 
The King Cobra is the least medically significant of the venomous 
snakes in India in terms of both bites and fatalities.  
Venon Apparatus44, 45  
 The Venom glands are surrounded by compressor muscles and 
are situated behind or below the eye. The venom duct opens the fang 
canal during the act of biting. The venom glands are squeezed by the 
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contraction of the compressor muscle and the venom is expressed 
through the grooved fangs. The snakes can inject doses of venom lethal 
to their natural prey in each up to 10 or more consecutive strikes. The 
quantity of venom injected is highly variable with no evidence that it 
can be adjusted according to the size of the prey or the intention of the 
snake. 
Venom composition: 
 Snake venom is a mixture of several compounds. These includes 
(90% enzymatic proteins) 
1) Neurotoxins 
2) Cholinesterase 
3) Fibrinolysins 
4) Proteolysins 
5) Haemolysins 
6) Thromboplastin 
7) Agglutinins 
8) Cardiotoxins 
9) Coagulase, hyaluronidase, lecithinase etc, 
Biogenic amines such as histamine and 5 hydroxytryptamine may 
be partly responsible for the pain of snake bite. 
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Table 3: Snake venom neurotoxins and their targets in the CNS.90 
Types of neurotoxin Functional target Source 
Short-chain 
neurotoxins 
Post-synaptic toxin; high 
affinity to skeletal and 
Torpedo nAChR; bind to 
neuronal α7 nAChR with 
lower affinity or none. 
Elapids and 
hydrophids (cobras, 
sea snakes, kraits, 
Australian elapids) 
Long-chain 
neurotoxins 
Post-synaptic toxin; 
comparatively higher 
affinity for neuronal α7 
nAChR than the skeletal 
receptors. 
Elapids and 
hydrophids (cobras, 
sea snakes, kraits, 
Australian elapids) 
Weak neurotoxins Post-synaptic toxin; weak 
affinity to both the skeletal 
and neuronal nAChRs 
Elapids (cobras, 
kraits, Australian 
elapids) 
Taipoxin Presynaptic toxin; binds 
specifically to neuronal 
plasma membranes 
especially at the 
neuromuscular junction. 
Australian elapid 
(taipan) 
β-Bungarotoxins Presynaptic toxin; 
presynaptic voltage 
dependent K+ channel 
Elapids (kraits) 
Muscarinic toxins Specific to mAChR 
subtype and bind with 
high affinity 
Elapids (mamba, 
kraits and cobras) 
 
nAChR, nicotinic acetylcholine receptor, mAChR, muscarinic 
acetylcholine receptor. 
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Table 4: Adhesion Molecule Recognition Motifs in Snake Venom 
Disintegrins70 
 
Motifs 
recognized by 
adhesion 
molecules 
Amino acid 
sequences 
Physiological 
target 
Examples  
source 
RGD Arginine-
glycine-
aspartate 
Blocks the 
GPIIb/IIIa receptor 
and binds to 
integrins αIIbβ3, 
α8bβ1, αvβ5 and or 
a5b1 
Trigramin 
(trimeresures 
gramineus); 
contortrostain 
(Agkistrodon 
contortrix 
contortrix) 
KGD 
 
Lysine-glycine-
aspartate 
Binds specifically 
to integrin αIIbβ3 
Barbuorin 
(Sistrurus 
m.barbouri) 
MVD Methionine – 
valine-aspartate
Potent inhibitor of 
both collagen – and 
ADP-stimulated 
platelet aggregation
Atrolysin-E/D 
(Crotalus atrox) 
MGD Methionine-
glycine-
aspartate
Potent and 
selective inhibitor 
of α5β1
EMF10-
(Eristocophis 
macmahoni) 
WGD Tryptophan-
glycine-
aspartate 
Potent inhibitor of 
the RGD-
dependent  
integrins α5β1, 
αvβ3, and 
αIIbβ3,integrins 
CC8 (Cerastes 
cerastes) 
MLD Methionine-
leucine-
aspartate 
Binds α4β1, α4β7, 
α9β1, α5β1 and 
αIIbβ3 integrins 
EC5 (Echis 
carinatus 
sochureki), 
VLO5 (Vipera 
lebetina obtusa) 
KTS Lysine-
tryptohan-
serine 
Selective integirn 
α1β1 inhibitors 
Obtustatin 
(Vipera lebetina 
obtuse) 
RTS Arginine-
tryptophan-
serine 
Selectively blocks 
integrin 1 α1 
Jerdostatin 
(Trimeresurus 
jendonii) 
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Clinical Features of Snake Bite 
 The evolution of symptoms and signs of envenomation depends 
on the nature of the venom, the dose and the site of injection46. The 
clinical features of snake bite can be divided into local and systemic. 
 Local manifestation: Local pain is the commonest symptom 
and usually starts within minutes of the bite. During the next few hours 
it intensifies, spreads towards the trunk and becomes localized in the 
lymph nodes draining the bite site. Some patients complain of vague 
abdominal or epigastric pain within six hours of bite. Local swelling at 
the site of bite or beyond is greatest around 1 to 4 days after bite 
(minutes to 48-72hrs). Both local pain and swelling is more in viper 
bite47. This is followed by edema, swelling and appearance of bullae 
which can progress rapidly to involve the trunk48. Tingling & 
numbness over the tongue, mouth, scalp and paraesthesia around the 
wound occur mostly in viper bites, local bleeding including petechial 
and ™™™or purpuric rash is seen most commonly with this family49. 
The local area of bite may become devascularized with features of 
necrosis predisposing to onset of gangrenous changes. Generally 
Elapid bites result in early gangrene usually wet type where as vipers 
cause dry gangrene of slower onset (over weeks). It is caused mainly 
by direct cytotoxic venom effect. 
25 
 
 There are two case reports of Raynaud’s phenomenon and 
gangrene in a limb other than that bitten by the snake, both bites were 
by Russell’s viper50. Secondary infection including tetanus and gas 
gangrene may also result51. 
 
Systemic Manifestations 
The most common and earliest symptom following snake bite is 
fright because of the risk of losing one’s life. Many patients present 
with symptoms which are the direct result of fright irrespective of 
whether it is a poisonous or non poisonous bite. Patients may complain 
of sudden onset of weakness, difficulty in breathing or swallowing, 
syncopal attack etc. These symptoms have to be differentiated from 
that of neurotoxicity52. 
The time of onset of envenomation is different in different 
species; Cobra produces symptoms as early as 6 to 8 minutes after the 
bite. Vipers take 6 to 15 minutes, however symptoms may be delayed 
for several hours, Sea snake bites almost always produce myotoxic 
features within 2 hours. Elapid venom are best known for their 
paralytic effect but cobra bite commonly cause severe local pain, 
swelling, blistering and tissue necrosis. Onset of paralysis may be 
delayed for 7-12 hrs after bite. These victims often present with 
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preparalytic symptoms like vomiting, heaviness of the eyelids, blurred 
vision, drowsiness and tingling sensation around the mouth. Paralysis 
first appears as bilateral ptosis and external ophthalmoplegia and then 
spreads to involve muscles of the palate tongue, jaw, larynx, neck and 
finally respiration. Later there is generalized flaccid paralysis. 
Consciousness is maintained provided there is no cardiac or respiratory 
failure. 
In general the viperidae venoms are best known for their severe 
local manifestations, haematotoxic effects, renal failure and cardiac 
involvement. In none of the studies done in other countries was the 
presence of neurological manifestation or myalgia recorded53. 
Occasionally Russell viper’s systemic envenomation may develop in 
the absence of local reactions. Spontaneous systemic bleeding result 
from haemorrhagins which damage vascular endothelium and the 
blood does not coagulate due to consumption coagulopathy, Russell 
viper venom activate factor V and X and cause fibrionolysis, Certain 
venoms cause defibrinogenation by activating endogenous fibrinolytic 
system54,55. All these effects result in bleeding from gum, nose 
(epistaxis), GIT bleeding (Haematemesis and malaena), kidney, 
urinary bladder (haematuria) and also from fang marks and 
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venepunture sites and even as multiple petechiae and purpura56. 
Subarachnoid hemorrhages and cerebral hemorrhage have also been 
reported. Hypotension and shock mainly result from hypovolemia 
resulting from massive hemorrhage or extravasation of fluid from the 
vascular compartment into the swollen limb. Vasodilatation and a 
direct action on the myocardium is mainly seen in viper bites. Almost 
every species of snakes can cause renal failure. It is fairly common 
following Russell’s Viper bite and is a major cause of death. 
Mechanism of renal damage include ischemia (from hypotension, renal 
vasoconstriction or disseminated intravascular coagulation), 
hemorrhage, direct nephrotoxicity or pigment nephropathy associated 
with massive intravascular haemolysis, generalized rhabdomyolysis 
and associated electrolyte disturbances. Acute interstitial nephritis due 
to snake venom have also been observed57. Cardiotoxic features 
include tachycardia, hypotension and ECG changes include sinus 
tachycardia, ischemic non specific ST-T changes and atrioventricular 
blocks. This cardiotoxicity is seen in 25% of Viperine bites54. Myalgic 
features are the most common presentation of bites by sea snakes. 
Muscle necrosis may also result is myoglobinuria. Rare systemic 
manifestations including hypopituitarism59 and bilateral thalamic 
haematoma60 have also been reported. 
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Late-onset envenomation43  
The patient should be kept under close observation for at least 24 
hours. Many species, particularly the Krait and the Hump-nosed pit 
viper are known for the length of time it can take for symptoms to 
manifest. Often this can take between 6 to 12 hours. 
Late onset envenomation is a well documented occurrence. This is also 
particularly pertinent at the start of the rainy season when snakes 
generally give birth to their  young. Juvenile snakes measuring 8-10 
inches long, tend to bite the victim lower down on the foot in the hard 
tissue area, and thus any signs of envenomation can take much longer 
to appear. 
Overlapping symptoms and signs43 
Russell’s viper envenomation can also manifest with neurotoxic 
features. This can sometimes cause confusion and further work is 
necessary to establish how wide this might be. Development of 
neurotoxic features in Russells Viper bite is believed to be pre synaptic 
or Krait like in nature. It is for this reason that a doubt is expressed 
over the response of both species to Neostigmine. 
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TABLE 5: SNAKES, CLINICAL RESPONSE AND 
THERAPEUTIC ASPECT43 
Features Cobras Kraits Russells 
Viper 
Saw Scaled 
Viper 
Hump 
Nosed Viper
Local Pain/Tissue 
Damage 
YES NO YES YES YES 
Ptosis / Neurological 
Signs 
YES YES YES NO NO 
Haemostatic 
abnormalities 
NO NO YES YES YES 
Renal Complications NO NO YES NO YES 
Response to 
Neostigmine 
YES  NO NO Not applicable 
Not 
applicable 
Response to ASV YES  YES  YES  YES NO 
 
MANAGEMENT64  
1. Do not send the patient away to another centre without first aid, 
especially if it is far away.  
2. Do not give sedatives to calm the patient. 
3. Do not tie a tourniquet above the site of bite.61 
4. Do not use ice packs, or incise, or perform suction at the site of 
bite.  
5. Do not elevate the limb unless antivenom is available 
immediately. 
6. Do not use antivenom unless specifically indicated.62,63  
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The mnemonic RIGHT gives the initial steps to be taken in a 
hospital or primary health care facility65 . 
R—Reassure the patient. Snake bite understandably causes great 
fear in the patient. Seventy per cent of all snake bites are non-
venomous. Even in bites by venomous snakes, envenomation occurs in 
only 50% of cases.  
I—Immobilize in the same way as you would a fractured limb, 
using splint and bandage. This goes a long way in slowing the spread 
of the venom in the body.  
G—Grade the degree of envenomation. This will help in 
assessing the need for dose of antivenom and the quantity of the initial 
dose.  
H—Admit the patient to the hospital even if your hospital is not 
equipped for such cases. Correct initial steps will ensure stabilization 
of the patient while transport is being organized.  
T—Take a blood sample. 
After the initial stabilization, which also includes assessment of 
the airway, breathing, and circulation, locally clean the wound, give 
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tetanus toxoid vaccine if the immunization is incomplete and insert a 
large bore intravenous line. A sample should be collected for Blood 
grouping. This should be done immediately before coagulopathy starts 
after which typing may be impossible.69  
Severity of envenomation67 
Grade 0—No envenomation—No local signs by six hours and no 
systemic signs by 24 hours.  
Grade 1— Minimal envenomation—Local swelling and pain without 
progression, with no systemic or lab abnormalities needs only pain 
control and careful observation.  
Grade 2—Moderate envenomation—Swelling, pain, or ecchymosis 
progressing beyond site of injury; mild systemic signs of nausea, 
vomiting, perioral and scalp paraesthesias and fasciculations, or lab 
manifestations in the form of evidence of coagulopathy. Antivenom 
should be given.68  
Grade 3—Severe envenomation—Marked local response with 
development of vesicles and bullae, systemic findings as in moderate 
plus hypotension, shock, bleeding diathesis and respiratory distress and 
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evidence of coagulopathy plus anemia and metabolic acidosis. 
Antivenom should be given.  
A progression of local swelling is best recognized if the circumference 
of bitten limb is taken every 15 minutes and a demarcation line is 
drawn on the upper limit of the initial swelling or the fang marks.  
Most envenomations become symptomatic in minutes and almost 
always within six hours. Delayed signs of envenomation have been 
reported in some species of snakes, especially kraits, so all patients 
with presumed dry snake bite should be admitted to hospital and 
observed for at least 24 hours. 
Antivenom 
In a setting with scarce antivenom, poor transport facilities, and 
inadequate laboratories, administration of antivenom is guided by the 
20 minute whole blood clotting test and clinical symptoms69. Perform 
the test every six hours. The protocol in the table is best suited for 
primary care facilities. 
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TABLE 6: PROTOCOL FOR PRIMARY CARE 
Frequency of 
evaluation 
Clotting time and 
neurotoxicity 
Antivenom in 1 hour 
(ml) 
Hourly  >20min or presence of 
neurotoxicity or both 
80-100(first dose) 
Second hour from 
first dose 
Worsening 
neurotoxicity
80-100 
Sixth hour from first 
dose and 
subsequently every 
six hours 
Still >20min 80-100 and 
subsequently every 
six hours till clotting 
time is normal 
Dilute antivenom in 100-500 ml of isotonic fluid or 5% dextrose. In 
case of neurotoxic bites, further worsening after two doses will require 
mechanical ventilation. Antivenom may not help at this stage70. In 
viperine bites repeat antivenom every six hours until coagulopathy is 
corrected. 
 
Adverse reactions to antivenom 
 Fear of anaphylactic reactions to antivenom is common among 
clinicians. These reactions are easily handled even in the smallest 
hospital if proper precautions are taken and healthcare workers are 
aware of the signs of anaphylaxis – urticaria, itching, fever, shaking 
chills; nausea, vomiting, diarrhea, abdominal cramps, tachycardia, 
hypotension, bronchospasm and angioedema. In cases of anaphylactic 
reactions stop giving antivenom. Give 0.5mg of 1:1000 adrenaline 
intramuscularly. To provide protection against delayed anaphylactic 
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reaction give 100mg (2mg/kg) of hydrocortisone intravenously, and 
give 0.2mg / kg of the H1 antihistamine chlorpheniramine maleate 
intravenously. If the symptoms do not improve in the next 10-15 
minutes, give another intramuscular dose of 0.5mg adrenaline. A third 
dose may also be given if necessary. Once the patient has recovered, 
antivenom can be restarted slowly for 10-15 minutes under close 
observation. Normal drip rate may then be resumed. Anaphylaxis to 
antivenom is not a contraindication to further administration of 
antivenom. Sensitivity test to antivenom has been abandoned. They 
have no predictive value in anaphylactic or late serum reactions and 
may pre sensitize the patient to the serum. 
Supportive treatment71 
The following supportive treatments may be needed. 
• Blood or blood products for disseminated intravascular 
coagulation. 
• Ventilator support for respiratory failure. 
• Use of ant cholinesterase agents for reversal of paralysis (0.5 mg 
neostigmine intramuscularly every half hour up to six doses and 
0.6 mg atropine intravenously, if the patient visibly improves 
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after the first dose. This should be started with the first evidence 
of neurotoxicity.  
• Peritoneal dialysis in case of renal failure. 
• Surgery if compartment syndrome develops. 
Patients receiving antivenom should be followed up for several days 
because delayed reactions can occur and their frequency is proportional 
to the amount of antivenom given.  Even without immediate access to 
tertiary healthcare facilities, much can be done to improve patient’s 
chances of survival. Proper first aid, availability of antivenom, 
determining the severity of envenomation, and overcoming the fear of 
anaphylaxis are four of the major areas which must be addressed. 
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AIMS AND OBJECTIVES 
To analyze the epidemiological and management aspects of poisonous 
snake bites admitted at GRH Madurai involving  
1) Snake bite 
2) Treatment behavior 
3) Symptoms and complication analysis 
4) Management aspects 
5) Economic burden 
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MATERIALS AND METHODS 
 
The study was conducted from December 2009 to December 
2010 with permission from the Department of Medicine, Government 
Rajaji Hospital, Madurai Medical College, Madurai. 
SOURCE OF DATA 
129 cases of snake bite admitted in Govt. Rajaji Hospital 
INCLUSION CRITERIA 
1) History of snake bite with/without fang marks with clotting time 
more than 20min 
2) History of snake bite with/without fang marks with neurological 
symptoms/signs 
EXCLUSION CRITERIA 
1) History of snake bite without signs/ symptoms of envenomation 
and clotting time less than 10 min. 
2) Patients who got discharged against medical advice 
           Symptoms of envenomation included 
A. Hemotoxic- bleeding manifestations from skin and 
mucous membrane in the form of frank hemorrhage to 
ecchymosis or petechae, abdominal pain. 
B. Neurotoxic- any form of motor weakness, respiratory 
effort weakness, altered neurological state. 
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  Signs of envenomation included 
a.  CT more than 20min, progressive cellulitis, skin and/or 
mucous membrane bleeding manifestations and neurological 
deficits. 
METHODS 
 A detailed history of bite including time of bite, site of bite, type 
of snake, first aid history, immediate manifestations and history of 
treatment received from outside were taken from each patient and from 
the witness. A detailed clinical examination of every patient was done 
with a standard proforma. 
 A set of investigations like complete blood count, BT, CT,  urea, 
creatinine, electrolytes and ECG were done for each patient, All 
investigation were repeated to evaluate the progress during and after 
treatment. Clinical progress was assessed every day. All the patients 
received antisnake venom according to the grading and progression of 
signs and symptoms. All patients received prophylactic antibiotics and 
surgical intervention like fasciotomy was done for patients who had 
severe local edema with compartment syndrome. 
      Patients were subjected to CT brain if intracranial hemorrhage was 
suspected. Those who developed ARF underwent hemodialysis until 
recovery.    
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RESULTS 
TABLE 7: AGE AND SEX CROSS TABULATION 
AGE SEX TOTAL 
FEMALE MALE 
13-22 11 
42.3% 
15 
57.7% 
26 
100.0% 
23-32 10 
37.0% 
16 
59.3% 
27 
100.0% 
 
33-42 10 
38.5% 
16 
61.5% 
26 
100.0% 
43-52 8 
32.0% 
17 
68.0% 
25 
100.0% 
53-62 9 
39.1%
14 
60.9%
23 
100.0%
63+ 0 
0% 
2 
100.0% 
2 
100.0% 
Total 48 
37.2% 
80 
62.0% 
129 
100.0% 
The incidence of snake bite among females was maximum in the age 
group of 13-22years (42.3%) and minimum in the 43-52(32%) age 
group. Among males the maximum incidence was observed in the 43-
52(68%) age group and minimum in the 63+years (100%) age group. 
 
Although the percentage distribution among males and females did not 
show wide disparity in their respective age groups, the frequency 
distribution was maximum(11) in the 13-22years age group for females 
and (17) for males in the 43-52years age group. 
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TABLE 8: OCCUPATIONAL DISTRIBUTION 
OCCUPATION FREQUENCY PERCENT 
 Farmer 69 53.5 
 Others 60 46.5 
Total 129 100 
 
The study showed that 53.5% of the bites occurred in the farming 
community. The remaining was among people of other professions. 
 
TABLE 9: TYPE OF SNAKE BITE 
TYPE FREQUENCY PERCENT 
Haemotoxic 117 90.7 
Neurotoxic 9 7.0 
Not available 3 2.3 
Total 129 100.0 
 
The incidence of haemotoxic snake bites was 90.7% and neurotoxic 
was 7%. Another 2.3% was unknown 
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TABLE 10: SITE OF BITE 
SITE OF BITE FREQUENCY PERCENT 
Forearm left 1 .8 
Left foot 49 37.7 
Left hand 8 6.2 
Left leg 11 8.5 
Forearm Right 1 .8 
Right foot 40 30.8 
Right hand 9 6.9 
Right leg 9 6.9 
Shoulder 1 .8 
Total 129 100 
 
Maximum number of bites was noted in the lower extremities 
89(68.5%). The left foot bite incidence was 49(37.7%) being 
marginally more than the right 40(30.8%). Other sites in decreasing 
order were left leg (11%), right hand and leg being (9%), left hand 
(8%) and left forearm, right forearm, and shoulder being 1% 
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TABLE 11: BITE SITE TO HOSPITAL DISTANCE 
DISTANCE(Km) FREQUENCY PERCENT 
<25 58 45.0 
25-49 38 29.5 
50-74 6 4.7 
75-99 6 4.7 
100-124 10 7.8 
175+ 2 1.6 
Total 129 100.0 
 
The study showed that the mean distance travelled by patients to 
reach the hospital was 37.61Km with the median being 30Km. It was 
observed that the maximum frequency distribution was below the 
25Km mark. 
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TABLE 12: TIME OF SNAKE BITE 
TIME GROUP(Hrs) FREQUENCY PERCENT 
< 3:00 2 1.6 
3:00 - 5:59 6 4.7 
6:00 - 8:59 20 15.5 
9:00 - 11:59 13 10.0 
12:00 - 14:59 19 14.7 
15:00 - 17:59 12 9.3 
18:00 - 20:59 41 31.8 
21:00 - 23:59 16 12.4 
  
Eight categories were made on the basis of three hourly intervals and 
the incidence of snake bite was analyzed. It was found that there were 
two peaks in the frequency curve. The maximum incidence of snake 
bite was observed between 6-9pm (31.8%) followed by 6-9am 
(15.5%).  
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TABLE 13: SEASONAL INCIDENCE 
MONTH FREQUENCY PERCENT 
1 14 10.9 
2 8 6.2 
3 12 9.3 
4 7 5.4 
5 7 5.4 
6 12 12.4 
7 9 7.0 
8 8 6.2 
9 7 5.4 
10 8 6.2 
11 18 14.0 
12 15 11.6 
Total 129 100.0 
 
The study showed the peaking of the incidence during the months of 
November, December and January (14%, 11.6% and 10.9% 
respectively). Another peak was observed in the month of June 
(12.4%) coinciding with the monsoon rains. 
 
45 
 
TABLE 14: TREATMENT SEEKING BEHAVIOR 
ATTRIBUTES PERCENTAGE FREQUENCY 
Traditional healer 11.6 15 
Traditional medication 12.4 16 
Tourniquet 63.6 82 
 
It was observed that 11.6% of the patients were taken to 
traditional healers before admission to the hospital. Another 12.4% 
consumed traditional medication before seeking help from tertiary 
referral center.  
 
Tourniquet application was observed in 63.6% of the cases. 
None of the patients were immobilized before admission for lack of 
awareness. 
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TABLE 15: BITE TO NEEDLE TIME 
TIME (Hrs) FREQUENCY PERCENT 
<3.00 26 20.0 
3.00 – 5.99 39 30.0 
6.00 - 8.99 30 23.9 
9.00 - 11.99 15 11.5 
12.00 - 14.99 5 3.8 
15.00 - 17.99 8 6.2 
18.00 - 20.99 4 3.1 
21.00 - 23.99 1 .8 
24.00+ 1 .8 
Total 129 100 
 
  
The study showed that the average bite to needle time was 6.9 hours 
with a median time of 5.5 hours. The maximum frequency distribution 
was in the 3-6 hour class interval. 
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BITE TO NEEDLE TIME AND ITS IMPLICATIONS ON THE 
OUTCOME 
 
To analyze the significance of bite to needle time with respect to 
its prognosis, the available frequency data of the time interval between 
the bite and anti snake venom administration was grouped into three 
hourly intervals. The prognosis in terms of the occurrence of major and 
minor complications was analyzed among the individuals in the three 
hourly intervals. Major complications included respiratory failure, 
ARF, ICH, DIC and fasciotomy. 
 
The analysis showed that there was a significant increase in the 
rate of complications both major and minor in those who had bite to 
needle time more than 6 hours Neurological complications in particular 
showed significant increase in complication rates. 
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TABLE 16(A): SYMPTOMS COMPARISON < & > 6Hrs BITE 
TO NEEDLE TIME 
SYMPTOMS <=5.931(Hrs)(%) 
>=5.931(Hrs) 
(%) 
Dyspnea 4.6 10.9 
Hemoptysis 1.5 3.1 
Ptosis 1.5 9.4 
Dysphagia 1.5 7.8 
Dysphonia 1.5 7.8 
Diplopia/Vision 
disturbance 
1.5 9.4 
Confusion 1.5 4.7 
Hematuria 16.9 25.0 
Hematemesis 3.1 3.1 
Gum bleed 3.1 1.6 
Malena 10.8 10.9 
Hemolysis 1.5 3.1 
Oliguria / anuria 15.4 21.9 
Malena 6.2 10.9 
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TABLE 16(B) : SIGNS COMPARISON < & > 6HRS BITES TO 
NEEDLE TIME 
SIGNS 
<=5.931(Hrs) 
(%) 
>=5.931(Hrs) 
(%) 
Cellulitis 87.7 82.8 
Regional lymphadenitis 70.8 71.9 
Compartment syndrome 9.2 6.3 
Cellulitis, regional lymphadenitis and compartment syndrome did not 
show any significant difference with respect to bite to needle time 
being more than or less than six hours.  
TABLE 16(C) : COMPLICATIONS COMPARISON < & > 6hrs 
BITE TO NEEDLE  TIME 
COMPLICATIONS <5.931(hrs) 
(%) 
>5.931(hrs) 
(%) 
ARF 15.4 23.4 
Fasciotomy 6.2 7.8 
Respiratory Failure 1.5 7.8 
ICH 1.5 100.00 
DIC 100.0 1.6 
Major complications like ARF, fasciotomy, respiratory failure, 
ICH and DIC were significantly higher in those individuals in whom 
the bite to needle time was more than six hours. 
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TABLE 17:  VIALS OF ASV ADMINISTERED 
 
NO. OF VIALS PERCENT 
< 5 17.1 
6-10 38.0 
11-15 24.0 
16-20 13.2 
21-25 3.9 
26+ 3.9 
Total 100.00 
 
The average requirement of ASV was found to be 12.8 vials with 
maximum frequency distribution in the 6-10 class interval. 
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TABLE 18 : PROPHYLACTIC EFFECTIVENESS OF CPM 
 
SYMPTOMS CPM ABSENT 
CPM 
PRESENT 
CHI 
SQUARE 
TEST 
 
SIGNIFICANCE
Vomiting 24.1% 78.6% .008 Significant 
Headache 31.6% 68.4% .023 Significant 
Paraesthesia 43.8% 56.3 .244 Not Significant 
Abdominal 
Pain 
27.3% 72.7% .052 Not Significant 
Giddiness 50.0% 50.0% .478 Not Significant 
 
The casual use of chlorpheniramine maleate and its rationale was 
assessed in the study. Applying the chi square test, it was found that 
the relative increase in symptoms as noted in the table above did not 
have any relation to the administration of CPM. 
However vomiting and headache symptoms were significantly higher 
in those who were administered CPM. 
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TABLE 19 : CPM AND ANAPHYLAXIS 
ATTRIBUTES CPM ABSENT CPM PRESENT 
No Anaphylaxis 53.5% 46.7% 
Anaphylaxis 42.9% 57.1% 
Chi-square 0.439 NOT SIGNIFICANT 
 
The study showed that administration of CPM did not have any 
significant relation with the occurrence of anaphylaxis. 
 
TABLE 20:  HEMODIALYSIS 
 
No. of cycles of HD Frequency Percent 
3-5 11 8.5 
6-8 8 6.2 
9-11 4 3.1 
39+ 1 8 
 
The maximum distribution of frequency was in the 3-5 class interval. 
Majority of the patients going in for ARF recovered with 3-5 cycles of 
hemodialysis. 
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OUTCOMES 
Of the 129 cases studied, five died and the others improved. Three out 
of the five deaths were due to septicemia and another two form 
metabolic complications. 
TABLE 21 :  EXPENDITURE TO REACH HOSPITAL 
 
  RUPESS FREQUENCY PERCENT 
Valid 
< 500.00 68 52.7 
500.00 - 999.00 22 17.1 
1000.00 - 1499.00 14 10.9 
1500.00 - 1999.00 7 5.4 
2000.00 - 2499.00 4 3.1 
2500.00+ 4 3.1 
Total 119 92.2 
Missing System 10 7.8 
Total 129 100.0 
 
It was observed that patients spent an average of Rs.609 to reach the 
hospital. The median being Rs.310 and maximum expenditure being 
Rs. 5000. 
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TABLE 22 :  LOSS OF PAY TO PATIENT 
 
AMOUNT IN 
RUPEES PER DAY
PERCENT 
< 100 36.4 
100-199 26.9 
200-299 4.6 
300-399 0.0 
400+ 3.1 
 
 
The study revealed that the mean loss of pay to the patient per day was 
Rs. 146 and the median was Rs. 90. The loss of pay was in the range of 
Rs. 20-600. 
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TABLE 23 :  LOSS OF PAY TO THE ATTENDEES’ 
  
AMOUNT IN RUPEES 
PER DAY 
FREQUENCY PERCENT
Valid 
< 150.00 52 40.3 
150.00 - 299.00 56 43.4 
300.00 - 449.00 11 8.5 
450.00 - 599.00 5 3.9 
600.00 - 749.00 1 .8 
750.00+ 2 1.6 
Total 127 98.4 
Missing System 2 1.6 
Total 129 100.0 
 
The study showed attendees’ of the patient lost on an average Rs. 
183.85 per day with a median of Rs. 150 and the maximum loss being 
Rs. 2500. 
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TABLE 24 :  DAILY EXPENDITURE 
AMOUNT IN 
RUPEES PER DAY 
FREQUENCY PERCENT
< 150.00 62 48.1 
150.00 - 299.00 43 33.3 
300.00 - 449.00 16 12.4 
450.00 - 599.00 5 3.9 
600.00 - 749.00 2 1.6 
900.00+ 1 .8 
Total 129 100.0 
 
The in hospital stay cost the patient on an average Rs. 173 per day with 
median of Rs. 150. The maximum spending was Rs. 1000 . 
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TABLE 25 :  GOVERNMENT SPENDING 
 
Amount in Rupees  Frequency Percent 
< 5000.00 21 16.2 
5000.00 - 9999.00 68 52.3 
10000.00 - 14999.00 30 23.1 
15000.00 - 19999.00 8 6.2 
25000.00+ 2 1.5 
Total 129 99.2 
 
 
The average spending by the health department per snake bite patient 
was Rs. 8640 with a median of Rs. 8238. The maximum expenditure 
being Rs. 27,428. 
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Statistical Methods : Chi-square and Fisher Exact test has been used 
to find the significance. Odds ratio has been used to find the strength of 
relationship between the parameters of interest. 
 
1. Chi-Square Test 
χ2 = ∑ (Oi – Ei)2,  Where Oi is observed frequnecy and Ei is Expected 
frequency  
    Ei 
2. Fisher Exact Test 
 Class 1 Class 2 Total 
Sample 1 a B a + b 
Sample 2 c D c+d 
Total a+c b+d n 
 
     (a+b)! (c+d)!(a+c)!(b+d)!        1 
Fisher Exact Test Statistic = ∑p = 
       n! 
 ∑a!b!c!d! 
 
 
Statistical software : The Statistical software namely 
SPSS 11.0 and Systat 8.0 were used for the analysis of the data 
and Microsoft word and Excel have been used to generate 
graphs, tables etc. 
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DISCUSSION 
 Snake bite is one of the greatest public health problems in the 
tropics. It is an occupational hazard of agricultural workers and hunters 
in many tropical countries. Snake bite mortality in India is about 
15,000 per annum, whereas the world mortality is estimated at 1, 
50,000 per annum. It is difficult to ascertain the correct incidence of 
snake bites as large number of cases go unregistered.  
Indian subcontinent, being tropical, harbors a variety of 
venomous and non-venomous snakes. The major families of snakes in 
India are Elapidae, Viperidae and Hydrophidae  (Bawaskar, 2004). The 
four major venomous biting species “The BIG FOUR” are Cobra (Naja 
naja), Krait (Bungarus caeruleus), Russell’s viper (Vipera russelli), and 
Saw-scaled viper (Echis carinatus). The former two belong to the 
Elapidae and the latter two belong to the Viperidae family16. 
 
AGE  
 
In the present study, most of the male victims were in the 43-52 age 
group (68%) whereas the female victims where in the 23-32 age group 
(37%). Both put together, the maximum number of victims were in the 
23-32 age group. A similar study conducted by Virmani SK and Dutt 
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OP36 in Jammu showed maximum incidence in the age group of 21-30 
years. 
In a similar study conducted in JIPMER, Pondicherry, majority 
of the victims were in the age group of 15-60 years73, whereas the 
study in Safdarjung Hospital, New Delhi and Sawai et al showed 
majority of the victims were in the age group of 10-30 years17. 
 The results of the present study are in accordance with the above 
mentioned studies which showed a rapid decline in the incidence of 
snake bite poisoning after the 5th decade of life. 
Sex 
The present study showed a male female ratio of 5:3 consistent 
with the report from the study conducted at JIPMER, Pondicherry73 
and Safdurjung Hospital, New Delhi and one another study conducted 
by Banerjee RN74. 
Occupation: 
 Consistent with the studies conducted at JIPMER, Pondichery, 
Safdarjung Hospital, New Delhi, the present study also showed that the 
incidence of snakebite poisoning was more among  people employed in 
the agriculture sector (30%) compared to other occupations. The 
characteristics of snakebite have been attributed to the risk of exposure 
61 
 
of these people to the snakes during their activities. This also shows 
that the high-risk group is the low socioeconomic section of the 
population. 
Domicile: 
 Rural people comprised the largest group of victims (92% 
cases), as the snakes are in abundance in the rural areas and the people 
living are closer to the latters habitat. 
 This study correlates with the study of Bhat RN (92%) and 
Kularatana SAM (96%), thereby indicating that snakebite poisoning 
remains a major public health problem among rural population. 
TYPE OF SNAKE BITE 
The present study showed hemotoxic(viperidae) snake bites 
contributing 117(90.7%) of the cases and only 9 (7%) of the cases were 
neurotoxic in nature. This is contrary to the reports from studies done 
at Safdurjung77 which showed a higher incidence of neurotoxic snake 
bites. This probably is attributed to the varying snake species 
distribution in south india. In our study most of the patients identified 
the type of snake whether belonging to viperidae or elapidridae group. 
About 3% of the patients could not identify the type of snake. 
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SITE OF BITE 
Maximum number of bites was noted in the lower extremities 
89(68.5%). The left foot bite incidence 49 (37.7%) was marginally 
more than the right 40 (30.8%). Other sites in decreasing order were 
left leg (11%), right hand and leg being (9%), left hand (8%) and left 
forearm, right forearm, and shoulder being 1%.  
These findings suggest that the site of snakebite is 
predominantly determined by accidental or inadvertent contact of the 
reptile during human activities. These findings are similar to that of 
Virmani SK36, Dutt OP and Bhat RN76. 
 TIME OF SNAKE BITE 
Our study showed that the maximum number of snake bites 
occurred between 6 pm to 9 pm (31.8%) and 6am to 9 am (15.5%). 
 A similar study conducted by Sawai et al117 showed a maximum 
incidence of snake bites between 6 PM and midnight. 
SEASONAL INCIDENCE  
This study proves the fact that there is a definite seasonal pattern 
in snakebite incidence. About 36% of cases were reported in the 
months of November, December and January and another 12% 
63 
 
reported in June. This is due to the fact that these are the monsoon 
months with rainfall forcing the snakes to venture out of their water-
filled pits, as well as there is increased human activity in the fields, 
being the sowing season. A similar trend was observed by Viramani 
SK and Dutt OP36. 
TREATMENT SEEKING BEHAVIOR 
Our study showed that 11.6% of the patients were taken to 
traditional healers before admission to the hospital. Another 12.4% 
consumed traditional medication before seeking help from tertiary 
referral center.  
Tourniquet application was observed in 63.6% of the cases. 
None of the patients were immobilized before admission for lack of 
awareness. A similar study conducted by Atta Muhammad chandio             
et al89  in sindh Pakistan revealed a similar practice of tourniquet 
application and seeking local treatment before reaching tertiary centers. 
In the present study the practice of incising the bite site was not 
prevalent as reported in the study conducted by Atta Muhammad 
chandio et al89 or by Bhat RN76.  
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CLINICAL FEATURES 
HEMATOLOGICAL MANIFESTATIONS 
Bleeding manifestations such as gum bleeding was observed in 3 
cases(2.3%), hemoptysis in 3 cases(2.3%), hematuria in 27 
cases(20.9%), hematemesis in 4 cases(3.1%), malena in 14 
cases(10.9%), ICH in 1 case and DIC in 1 case Virmani S.K.36 in his 
study reported haematuria as the commonest (67.2%) presentation 
followed by bleeding  gums (36.2%), bleeding from injection site 
(39.7%) haemoptysis (18.1%), haemetemesis (28.4%), malena (25.4%) 
and epistaxis (12.5%). In out study epistaxis was not observed in any 
of the cases. 
NEUROTOXIC MANIFESTATIONS 
Neurotoxic manifestations observed were as follows. Paraesthesia in 
27 cases(20.9%), headache  in 34 cases (26.4%), dyspnea in 10 cases 
(7.8%), ptosis in 7 cases (5.4%), dysphagia in 6 cases (4.7%), 
dysphonia in 6 cases (4.7%) diplopia and vision disturbance in 7 cases 
(5.4%) and respiratory paralysis in 6 cases (4.7%). Convulsions were 
not observed in any of the cases in the study. 
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COMPLICATIONS 
Fasciotomy was done in 9 cases (7%), ARF in 24 cases (18.6%), 
cellulitis in 110 cases (85.3%), compartment syndrome in 10 cases 
(7.8%) and anaphylaxis in 7 cases (5.4%). 
BITE TO NEEDLE TIME 
 Time interval between snakebite and administration of ASV 
carries a prognostic importance. Lesser the time interval better the 
prognosis. The delay in seeking medical help is mainly due to time 
spent in administering home remedies and getting treatment from 
traditional practitioners and also lack of transport facilities especially 
during nights. 
 
 Early hospitalization (below 6 hours) was shown to reduce the 
incidence of mortality, morbidity and the duration of hospital stay. 
 
To analyze the significance of bite to needle time with respect to 
its prognosis, the available frequency data of the time interval between 
the bite and ASV administration was grouped into three hourly 
intervals. The prognosis in terms of the occurrence of major and minor 
complications was analyzed among the individuals in the three hourly 
intervals. 
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The analysis showed that there was a significant increase in 
complications rates in those who had bite to needle time more than 6 
hours. Neurotoxic snake bites in particular showed significant increase 
in complication rates. These findings are similar to the observation 
made by Vijeth SR et al81   and Ash T et al82. 
  
ASV REQUIREMENT 
In the present study the majority of the cases required between 
6-10vials of ASV compared to the previous conventional high dose 
regimen. 
A study conducted at RNT Medical College83. Udaipur 
Rajasthan concluded that low dose continuous infusion is an effective 
and economical mode of treatment. Christian Medical College84and 
Hospital Vellor and Baptist Hospital, Bangalore too concluded that the 
low dose regimen is as effective as the conventional one. 
 One more study at JIPMER, Pondichery by Vijeth SR81 et al 
suggested, initial dose of ASV should be between 150-200 ml if blood 
is found coagulable at the time of admission. Any patient subsequently 
developing incoagulable blood should be given 100 ml of ASV. 
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Another study at JSS Medical College86, Mysore suggested that 
the dose depends on clinical effects, rather than on age or weight. 
 
PROPHYLACTIC EFFECTIVENESS OF CPM IN 
PREVENTING ANAPHYLAXIS 
Patients who were administered prophylactic CPM and those 
who were not, were analyzed for the incidence of symptoms and 
complications. The chi-square analysis of  symptoms showed 
significance with respect to symptoms of vomiting and headache but 
showed no association with paraesthesia, giddiness or abdominal pain.  
Anaphylactic reactions were noted in 7 cases (5.4%) with a 
mortality of 1 which was resistant to treatment. Banerjee RM et al87 
also reported anaphylactic reactions in 3% of cases with no mortality. 
The other significant result the study showed was that there was 
no association with the prophylactic use of CPM and prevention of 
anaphylaxis. A similar sequential randomized and double blind trial 
using histamine blocker promethazine, for the prophylaxis against 
early  anaphylactic reactions to antivenom for bothrops snake bites by 
Hui Wen Fan88showed the absence of effectiveness of prophylactic use 
of H1 blockers in preventing anaphylactic reactions. 
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COMPLICATIONS AND OUTCOME 
In the present study, three patients developed respiratory failure and 
received ventilator support for a mean period of three days and twenty 
four patients underwent hemodialysis for acute renal failure. The 
morbidity was more for hemotoxic snake bites developing renal failure 
as the hospital stay increased by an additional five days on an average 
requiring about 3-5 cycle of HD. Of the five patients who died, three 
were due to ARF with sepsis and another two encountered sudden 
death probably due to metabolic causes. 
 
ECONOMIC BURDEN 
Money spent by a victim to reach the hospital on an average was less 
than Rs. 200. The average distance travelled to reach the hospital was 
about 25Km. Majority of the victims used the public mode of transport. 
Others were brought by 108 ambulance service or private transport. 
Victims in the age group of 43-52 yrs constituted the most number of 
cases and about 53.5% of them were involved in farming and related 
activities. The average in hospital stay was 4.5 days thereby incurring a 
wage loss of Rs.150-300 to the patient.   
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The economic burden was also shared by the attendees’ who 
themselves where daily wage earners in the range of Rs. 150-300. 
The daily expenses in terms of food and miscellaneous expenditure 
was about Rs. 150.  With the average stay in the hospital being 4.5 
days, the total expenditure amounted to Rs. 2925. 
Government spending 
The average spending by the health department per snake bite patient 
was Rs. 8640 with a median of Rs. 8238. The maximum expenditure 
being Rs. 27428. The cost of ASV accounted for the most part of the 
expenditure. Those patients who developed ARF cost the government 
an additional Rs5000-7000. 
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SUMMARY 
 This study was conducted at Government Rajaji Hospital, 
Madurai Medical College, Madurai  between December 2009 to 
December 2010. A total  of 129  poisonous snake bite cases were 
analysed. Following points of each patient was noted – name, age, sex, 
occupation, address, date and time of bite, time interval between bite 
and ASV administation, site of bite, and first aid measures given. 
 
Each patient was examined  for local as well as systemic signs of 
envenomation, Each patient was subjected to the following 
investigations: Hb%, TLC, DLC, Bleeding time, cloting time, blood 
urea, serum creatinine, serum electrolytes ECG and other 
investigations whenever required. 
 
Treatment measures included: 
1. General: Inj. Tetanus toxoid, antibiotics, steroids, IV fluids, 
analgesics. 
2. Specific: ASV, neostigmine, atropine, blood transfusion, assisted 
ventilation, diuretics and dialysis. 
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The following were noted in the study 
1) The incidence of snake bite among females was maximum in the 
age group of 13-22 (42.3%) and minimum in the 43-52 (32%) age 
group category. Among males the maximum incidence was observed 
in the 43-52(68%) age group and minimum in the 63+years (100%) 
age group. 
Although the percentage distribution among males and females did not 
show wide disparity in their respective age groups, the frequency 
distribution was maximum(11) in the 13-22years age group for females 
and 17 for males in the 43-52years age group. 
2) The study showed that 53.5% of the bites occurred in the farming 
community. The remainder was among people of other professions. 
3) The incidence of haemotoxic snake bites was 90.7% and neurotoxic 
was 7%. Another 2.3% was unknown. 
4) Maximum number of bites was noted in the lower extremities 
89(68.5%). The left foot bite incidence was 49(37.7%) being 
marginally more than the right 40(30.8%). Other sites in decreasing 
order were left leg (11%), right hand and leg (9%), left hand (8%) and 
left forearm, right forearm, and shoulder being 1%.  
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5) Mean distance travelled by patients to reach the hospital was 
37.61Km with the median being 30Km. It was observed that maximum 
frequency distribution was below the 25Km mark. 
6) The maximum incidence of snake bite was observed between 6-9pm 
(31.8%) followed by 6-9am (15.5%) and 12-3pm (14.7%).  
 7) Peak incidence of snake bite was in the months of November, 
December and January (14%, 11.6% and 10.9% respectively). Another 
peak was observed in the month of June (12.4%). 
8) It was observed that 11.6% of the patients were taken to traditional 
healers before admission to the hospital. Another 12.4% consumed 
traditional medication before seeking help from tertiary referral center.  
Tourniquet application was observed in 63.6% of the cases. None of 
the patients were immobilized before admission for lack of awareness. 
9) Average bite to needle time was 6.9 hours with a median time of 5.5 
hours. The maximum number of victims were in the range of 3-6 
hours. 
10) The study showed that complications, symptoms and signs 
especially with neurotoxic snake bites were significantly more and 
severe when the bite to needle time exceeded the crucial 6 hours. 
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11) Prophylactic use of CPM did not reduce the incidence of 
anaphylactic reactions although there was associated reduction in some 
of the minor symptoms. 
12) Majority of patients who had developed ARF recovered within 3-5 
cycles of HD. 
13) In the study 5 cases died, three due to septicemia and another two 
due to probable metabolic causes. 
14) The economic burden to the patient including charges to reach the 
hospital, daily expenses, loss of pay to the attendees’ and patient 
amounted to Rs. 2925 for an average stay of 4.5 days. 
15) The government spending per case of snake bite amounted to Rs. 
8640 on an average. 
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CONCLUSION 
 
Snake bite is a major cause of mortality and morbidity in India. 
This has significant socio-economic repercussions within the rural 
population, as more than 90% of the bites are reported from rural India 
with 54% of them being directly involved in farming. 
           About 90% of poisonous snake bites are hematotoxic and the 
average bite site to tertiary center distance being 37Km. Individuals are 
usually bitten between 6-9pm, with more than 90% of the bites on the 
feet while venturing into the wilderness. Snake bites are more common 
in the months of June, November, December and January when the 
monsoon rain in this part of the county forces the snakes to come out 
of their habitat. 
          Victims usually identify and bring the snake to the hospital with 
easy access to either public or private transport. Bite to needle time 
delay is determined by the distance travelled and time spent in getting 
local and traditional medication. This delay when more than 6 hours 
increased morbidity and mortality significantly. 
          The low dose regimen of 100 to 150ml ASV was as effective as 
the older high dose regimen and prophylactic medication to prevent 
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anaphylaxis proved to be ineffective. Timely ventilator support and 
hemodialysis significantly reduced mortality.  
Finally the Economic burden borne by the patient, care givers 
and health department continues to remains a major problem of snake 
bite in India. 
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1 28 M 3 C H FIELD LF 40 A 20:30 20 3 2:00 A A A A A P P A P A A A A A A A A A A A A A A P P A A A A A P 1000 300 250 250 10116 I
2 21 F 3 TAILOR NA NA FIELD LF 7 A 10:30 10 3 16:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A A 310 300 120 300 5616 I
3 14 M 4 STUDENT NA NA School RH 15 A 13:30 5 4 20:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A P P 600 300 NIL NIL 3738 I
4 45 F 4 C N FIELD RF 30 A 15:00 8 4 22:45 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 1000 150 50 50 5088 I
5 27 N 5 F H FIELD LF 12 A 11:45 15 5 15:00 A A A A A A P A A A A A A A A A A A A A A A A P P A A A P A P 70 300 150 150 8610 I
6 58 M 6 F H FIELD RF 0.5 A 21:30 10 6 2:50 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 200 100 NIL 200 6732 I
7 15 M 4 STUDENT NA NA FIELD LF 35 A 19:00 10 4 23:00 A A A A A A A A A A A A A A A A A A A A A A A P A A P P A A A 200 200 NIL 170 5988 I
8 22 M 6 STUDENT H FIELD LF 15 A 23:00 15 6 5:00 A A A A A A P A A A A A A A A A A A A A A A A P P A A A P A A 200 200 NIL 150 8982 I
9 13 F 3 STUDENT H HOME LF 25 A 6:00 10 3 11:00 A A A A A A A P A A A A A A A A A A A A A A A P A A A A P A P 350 150 NIL 150 5616 I
10 30 F 5 HOUSE WIFE H HOME RF 100 A 22:00 15 5 15:30 A A A A A A A A P A A A A A A A A P A P A A A P P A A A A A P 2500 300 NIL 60 8610 I
11 60 F 3 C H FIELD RH 35 A 16:00 15 3 18:30 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A P P 500 175 NIL 200 7866 I
12 18 M 5 C H FIELD LH 8 A 16:30 18 5 18:00 A A A A A P A A A P A A A A A A A A A A A A A P P A A A P P A 150 100 150 170 9960 I
13 35 M 4 C H FIELD RH 24 A 7:10 8 4 11:10 A A A A A P p A A A A A A A A A A A A A A A A P P A A A P A P 200 100 120 150 5088 I
14 20 M 4 LABOURER H FIELD RF 20 A 4:00 8 4 9:15 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 30 300 150 200 5088 I
15 30 F 4 F H HOME RH 25 A 20:00 5 4 16:30 A A A A A A A A A A A A A A A A A A A A A A A P P A P A P A P 500 100 50 50 3738 I
16 40 F 4 LABOURER H FIELD L.F.A 15 A 18:00 15 4 23:00 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A A 400 100 50 50 8238 I
17 18 M 3 SHOP KEEPER H FIELD LF 0.5 A 19:30 5 3 22:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A P NIL 60 150 100 3366 I
18 35 M 7 LABOURER H HOME LH 70 A 0:30 23 7 11:00 A P A A A P P A P P A A A A A A A A A A A A A A P P A A P A P 650 300 90 150 12954 I
19 17 M 4 STUDENT H HOME RL 50 A 20:00 15 4 3:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A P 300 200 NIL 100 8238 I
20 54 M 6 F N HOME R.F.A 30 A 23:00 15 6 13:00 A A P A A A P A A P P A P P P P A A A A A A A A A A A A A P A 1100 600 120 100 8982 I
21 50 M 4 F H FIELD RF 80 A 14:30 15 4 21:00 A A A A A A A A A P A A A A A p P A A A A A A P P A A A P P P 1300 50 100 50 8238 I
22 52 M 4 F H FIELD LF 40 A 19:00 15 4 2:00 A A A A A P P A P A A A A A A A A A A A A A A P P A A A P A P 700 200 70 50 8238 I
23 31 M 7 F H FIELD RF 50 A 8:45 15 7 17:00 A A A A P A A A P A A P A A A A A A P P P A P P P A A A P P A 1000 150 200 250 9354 I
24 25 M 7 DRIVER H FIELD LF 70 A 23:30 20 7 3:00 A P A A A A P A P A A A A A A A A A A A A A A P P P A A P A P 1600 300 150 150 11604 I
25 29 M 7 F H FIELD LF 50 A 20:00 30 7 1:30 A A A A A A A P P A A A A A A A A A A A A A A P P A A A A A A 700 150 200 100 16104 I
26 60 F 10 C H FIELD LF 25 A 23:00 20 10 1:30 A P A A A A P P A A A A A A A A A P P P A A P P P P A A A A A 0 100 100 150 12720 I
27 13 F 4 STUDENT H FIELD RF 10 A 21:45 15 4 0:30 A A A A A P A A A P A A A A A A A A A A A A A P P A A A P A A 50 75 NIL 40 8238 I
28 38 F 4 HOUSEWIFE H FIELD LF 20 A 19:00 11 4 21:00 A A A A A A A A A A P A A A A A A A A A A A A P P A A A A A P 700 50 NIL 6438 I
29 48 M 4 C H FIELD LF 25 A 6:00 15 4 21:00 A A A A A A A P A A A A A A A A A A A A A A A P P A A A P A P 500 100 150 175 8238 I
30 31 F 3 HOUSEWIFE H FIELD LF 45 A 10:30 15 3 21:00 A A A A A P A A A A A A A A A A A A A A A A A A A A P P P A P 100 100 150 200 7866 I
31 31 M 3 C H FIELD LH 35 A 9:00 10 3 11:30 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A A 200 120 130 100 5616 I
32 56 M 4 F H HOME LF 14 A 19:00 10 4 0:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 200 200 200 300 5988 I
33 23 M 3 C H FIELD LF 3 A 20:30 5 3 23:40 A A A A A A A A A A A A A A A A A A A A A A A P P P A A P A A 50 25 200 250 3366 I
34 25 M 3 C H FIELD RL 40 A 23:30 5 3 2:35 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 600 100 100 130 3366 I
35 45 F 16 F H FIELD RH 200 A 9:00 15 16 20:15 P 6 A A A A P P A P A A A A A A A A A A A A P A P P A A A P A P 2500 300 50 220 14802 I
36 20 F 3 C H FIELD LH 50 A 9:00 18 3 13:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 100 150 100 150 9216 I
37 58 F 16 F H FIELD LL 20 A 13:00 10 16 23:30 P 7 A A A A P P P P A A A A A A A P A A A A A A P P A P P P A A 600 120 150 200 12902 I
38 50 M 12 F N FIELD LL 79 A 5:20 33 12 0:00 A A P A A A P A A P P A P P P P A A A A A A A A A A A A A A A 840 1000 100 160 19314 I
39 18 F 5 C H HOME LF 30 A 14:30 10 5 16:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 300 100 50 50 6360 I
40 27 F 5 C H FIELD LF 30 A 7:00 10 5 10:00 A A A P A A A P A P A A A A A A P A A A A A A P P A P P A A P 450 500 50 390 6360 D
41 49 F 6 F H FIELD RF 45 A 9:00 18 6 16:00 A A A A A A P A P A A A A A A A A A A A A A A P P A A A P A P 250 150 150 95 10332 I
42 45 F 8 C H FIELD RH 35 A 12:30 18 8 23:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A P 200 20 35 80 11076 I
43 42 M 4 F H FIELD RF 25 A 3:00 10 4 10:15 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A P 150 100 150 90 5988 I
44 50 F 5 C H FIELD RL 50 A 20:00 10 5 1:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 2000 200 30 180 6360 I
45 35 F 6 C H FIELD RL 30 A 17:00 30 6 23:00 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A A 350 150 50 200 15732 I
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46 40 F 5 F H FIELD RF 40 A 4:00 15 5 9:00 A A A A A A A A A A A A A A A A A A P A A A A P A A P P A A A 1300 200 50 240 8610 I
47 24 M 4 DRIVER H ROAD RF 30 A 20:30 15 4 0:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 300 200 150 200 8238 I
48 60 M 5 F H FIELD LF 100 A 17:30 17 5 19:00 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A A 1400 300 100 360 9510 I
49 17 F 4 C H FIELD LF 40 A 16:00 10 4 22:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A A 2000 300 100 460 5988 I
50 40 F 14 F H FIELD LH 20 A 13:00 10 14 19:00 P 4 A A A A P P P P A A A A A A A A A A A A P A P P A A A A A A 500 180 130 160 11108 I
51 25 F 9 F N FIELD LF 40 A 20:00 10 9 15:00 A A P A A A P A A A P A P P P P A A A A A A A P P A P P P A A 500 200 200 700 7848 I
52 40 M 5 C H FIELD LF 14 A 20:30 10 5 22:15 A A A A A A A A P A A A A A A A A A A A A A A P P A A A A A A 400 200 150 150 6360 I
53 42 M 15 LABOURER N HOME SHO 40 A 23:00 15 15 7:00 A A P A A A P P A A P A P P P P A A A A A A A P P A A A P A P 1500 250 150 900 12330 I
54 23 M 3 C H HOME LH 120 A 18:00 10 3 3:00 A A A A A A A A A P A A A A A A A A A A A A A A A A A A A A A 1300 250 80 340 5616 I
55 30 M 5 F H FIELD LF 30 A 18:40 10 5 21:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 50 80 150 150 6360 I
56 50 M 3 C H FIELD RF 15 A 8:00 12 3 11:00 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A A NIL 50 100 80 6516 I
57 52 M 4 WASHERMAN H FIELD LF 3 A 18:00 10 4 9:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A NIL 150 150 150 5988 I
58 60 F 6 F H FIELD LL 90 A 19:00 20 6 4:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 1700 150 80 160 11232 I
59 45 F 15 LABOURER H FIELD RF 17 A 17:30 20 15 21:00 P 3 A A A A P P P P A A A A A A A A A A A A P A P P P A P P A P 1000 150 100 300 15630 I
60 26 M 16 LABOURER H FIELD LF 14 A 19:00 5 16 1:00 P 5 A A A A P A P P A A A A A A A A A A A A P A P P A A A A A P 300 150 100 500 9952 I
61 61 M 15 F H FIELD LF 90 A 20:00 10 15 6:00 P 4 A A A A P A P P A A A A A A A A A A A A P A P P A A A P A P 1000 150 200 400 11480 I
62 45 M 16 F H FIELD LF 55 A 19:00 10 16 20:30 P 6 A A A A P A A P P A P A A A A A P A P A P A P P A A A A A P 500 100 100 100 12552 I
63 35 F 24 F H FIELD RF 70 A 10:15 10 24 11:50 P 40 A A A A P A A P P A A A A A A A A A A A P A P P A A A P A P 1000 500 100 100 27428 I
64 35 F 21 F H FIELD LF 20 A 14:00 10 21 20:15 P 7 A A A A P A A P P A A A A A A A A A P A P A P P A A A P A A NIL 100 100 150 14762 I
65 54 M 6 F H FIELD RF 45 A 8:00 18 6 19:00 A P A A A A A A A A A A A A A A A A A A A A A P A A A A A A P 200 100 150 300 10332 I
66 29 M 15 F H FIELD RF 75 A 20:00 23 15 18:30 P 9 P P A A P P P P P P A P A A P P A A A A P P P P P A A P A P 750 500 50 500 13500 D
67 18 F 18 F H FIELD LF 16 A 12:00 15 18 13:15 P 6 A A A A P A A P P A A A A A A A A A P A P P P P A A A P A A 100 150 50 100 15546 I
68 18 M 13 STUDENT H FIELD RL 8 A 17:00 15 13 20:00 P 10 A A A A P P P P A A A A A A A A A A A A P P P P A A A P A A 60 500 NIL 450 15086 I
69 45 M 15 F H FIELD RF 90 A 9:00 10 15 12:15 P 4 A A A A P A A P A A A A A A A A A A A A P A P P A P P P A A 1500 700 150 230 11480 I
70 13 M 13 STUDENT H FIELD RF 120 A 22:00 12 13 10:00 P 8 A A A A P A P P A A P A A A A A A A P P P P P P A A P A A A 600 350 NIL 130 13036 I
71 45 M 12 F H FIELD LF 100 A 8:30 15 12 15:30 P 5 A A A A P A A P A A A A A A A A A A A A P A P P A A A P A A 350 120 150 150 12964 I
72 36 M 14 F H FIELD LF 180 A 16:00 10 14 19:20 P 9 A A A A P A P P P A A A A A A A A A P P P P P P A A A P A A 5000 100 40 60 12858 I
73 22 F 8 F H FIELD RF 30 A 10:30 10 8 18:30 P 3 A A A A P A P A A A A A A A A A A A A A P A P P A A A P A A 35 50 50 140 8526 D
74 15 M 13 STUDENT H FIELD LF 110 A 19:00 13 13 19:30 P 7 A A A A P P A P A A A A A A A A A A A A P A P P A A A P A P 2000 200 NIL 300 13136 I
75 24 F 12 F H FIELD LF 35 A 21:00 40 12 6:00 P 9 A A A A P P P P A A A A A A A A A A P A P P P P A A A P A P 300 150 40 50 25614 I
76 28 F 13 F H FIELD LF 65 A 19:00 5 13 1:00 P 6 A A A A P P A P P A A A A A A A A A P A P P P P A A A P A P 700 150 50 200 9186 I
77 45 M 10 F H FIELD RF 40 A 7:30 23 10 11:00 P 5 A A A A P A A P A A A A A A A A A A P A P A P P A A A P P P 2500 360 60 100 15820 D
78 55 M 3 F H HOME RF 30 A 20:30 10 3 21:45 A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A 500 50 100 50 5616 I
79 58 M 4 C H FIELD LF 4 A 20:15 10 4 21:00 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A A 20 80 120 100 5988 I
80 55 F 4 F H FIELD RF 20 A 12:00 5 4 20:10 A A A A A A A A A A A A A A A A A A A A A A A P A A A A P A P NIL 100 50 100 3738 I
81 18 F 5 WENDOR H FIELD LL 5 A 9:00 15 5 12:45 A A A A A A A A A A A A A A A A A A A P A A P P A A A P A P 100 150 100 200 8610 I
82 45 F 4 F H FIELD LF 50 A 14:30 15 4 5:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A P 100 50 250 250 8238 I
83 62 F 11 F H FIELD RH 70 A 22:00 13 11 15:00 P 3 A A A A P A P P A A A A A A A A A A A A P A P P A A A P A A 1500 60 150 300 9942 D
84 58 F 8 F H FIELD RF 10 A 13:00 10 8 23:30 P 4 A A A A P P P P A A A A A A A A A A A A P P P P A A A P A P 100 50 100 100 8876 I
85 56 M 5 F H FIELD LF 45 A 21:00 20 5 2:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A P 400 100 50 150 10860 I
86 18 M 4 F H FIELD RF 2 A 22:30 5 4 1:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A P 30 150 100 100 3738 I
87 50 M 7 F H FIELD LL 10 A 18:30 20 7 20:00 A P A A A P A A A A A A A A A A A A A A A A A P P P A A P A A 120 100 100 150 11604 I
88 27 M 3 F   H HOME RH 5 A 13:00 5 3 14:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A 200 100 250 250 3366 I
89 55 M 3 F N FIELD RL 55 A 10:30 5 3 2:30 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A A 200 100 200 150 3366 I
90 19 M 4 STUDENT H HOME RF 23 A 19:00 10 4 23:45 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A A 450 75 100 150 5988 I
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91 40 M 14 F H FIELD RF 24 A 20:00 10 14 21:30 P 3 A A A A P P P P A P A A A A A A A A A A P A P P A A A P A P 200 100 100 250 12858 I
92 46 M 5 F H FIELD LF 40 A 17:30 15 5 21:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 300 100 150 100 8610 I
93 63 M 3 F H FIELD RF 12 A 19:00 5 3 10:30 A A A A A A A A A P A A A A A A A A A A A A A A A A A A A A P 150 100 150 100 3366 I
94 35 F 5 F H FIELD RF 40 A 12:00 13 5 20:00 A A A A A P A A A A A A A A A A A A A A A A A P A A A A A A P 56 50 100 150 7710 I
95 20 F 6 C H FIELD RL 20 A 20:00 20 6 3:00 A P A A A A A A A A A A A A A A A A A A A A A P P P A A P A A 150 70 100 150 11232 I
96 47 M 3 C H FIELD RF 30 A 9:00 5 3 16:30 A A A A A A A A A A A A A A A A A A A A A A A P A A A A P A A 600 70 150 100 3366 I
97 21 M 4 F H FIELD LL 20 A 4:00 10 4 12:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A P 100 100 150 150 5988 I
98 65 M 3 F H FIELD RF 10 A 19:30 5 3 22:30 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A P 100 70 120 100 3366 I
99 35 M 11 F N FIELD RH 15 A 2:10 15 11 7:00 A A P A A A P A A A P A A P P P A A A A A A A A A A A A P A A 300 160 160 560 10842 I
100 52 M 3 F H FIELD LF 10 A 17:00 10 3 19:00 A A A A A P A A A A A A A A A A A A A A A A A P P A A A P A P 150 100 75 175 5616 I
101 28 F 8 F N FIELD RL 100 A 14:00 20 8 0:00 A A A A A P P P P P P A P P P P A A A A A A A A A A A A P A P 1500 200 100 150 11936 I
102 25 M 4 F H FIELD LF 20 A 18:30 15 4 23:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 150 100 80 100 8238 I
103 55 M 6 F H FIELD RF 1 A 13:30 25 6 16:45 A A A A A P A P A A A A A A A A A A A A A A A P P A A A A A P NIL 100 250 250 13482 I
104 40 M 5 SHEPARD H HOME LL 25 A 19:15 35 5 22:00 A P A A A A P A A A A A A A A A A A A A A A A P P P A A A A P 1000 300 100 50 17610 I
105 38 M 7 F H FIELD RF 7 A 20:15 10 7 22:00 A A A A A A A A A A A A A A A A A A A A A A P P A A A A A P 200 100 150 150 7104 I
106 41 M 6 F H FIELD RF 10 A 6:15 10 6 9:15 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A P 700 100 100 100 6732 I
107 47 M 7 F H FIELD LL 9 A 12:00 20 7 13:00 P 3 A A A A P A P P A A A A A A A A A A A A P A P P A A A P A P 100 150 90 160 12054 I
108 60 M 3 F H FIELD LF 13 A 10:30 10 3 15:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 100 50 20 50 5616 I
109 40 M 3 F H FIELD LF 20 A 7:00 5 3 14:00 A A A A A A A A A P A A A A A A A A A A A A A P A A A A P A A 100 50 50 50 3366 I
110 33 M 4 SUPREVISOR H FIELD LF 8 A 21:30 10 4 11:40 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 200 150 150 100 5988 I
111 45 M 3 F N FIELD LL 41 A 9:00 5 3 11:00 A A A A A A A A A A A A P A A A A A A A A A A A A A A A A A A NIL 200 100 40 3366 I
112 60 M 4 F H FIELD LL 100 A 19:00 10 4 4:00 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A P 1800 150 100 200 5988 I
113 16 F 3 STUDENT H FIELD LF 100 A 14:00 5 3 22:45 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A P 2000 50 NIL 100 3366 I
114 35 M 4 C H FIELD RF 13 A 11:00 5 4 13:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A NIL 100 250 100 3738 I
115 40 F 6 C H FIELD LF 12 A 9:30 10 6 15:30 A A A A A P A P P A A A A A A A A A A A A A A P P A A A P A P NIL 70 50 50 6732 I
116 47 M 7 F H FIELD RF 14 A 12:00 25 7 23:00 A A A A A P A P A A A A A A A A A A A A A A A P P A A A P A P 600 200 100 200 13854 I
117 60 M 3 F H FIELD RF 15 A 6:00 10 3 10:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A P A P 100 150 150 100 5616 I
118 25 F 3 C H HOME LF 50 A 22:30 8 3 1:30 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A A 180 50 80 100 4716 I
119 50 F 3 F H FIELD RF 40 A 11:00 5 3 16:00 A A A A A A A A A A A A A A A A A A A A A A A P A A A A A A A 1000 150 600 900 3366 I
120 25 F 3 C H FIELD RF 15 A 19:00 5 3 22:30 A A A A A A A A A A A A A A A A A A A A A A A P A A A A P A A 100 50 50 50 3366 I
121 39 M 4 ELECTRICIAN H HOME LF 18 A 3:00 5 4 23:00 A A A A A A A A A P P A A A A A A A A A A A A P A A A A A A P 300 100 500 175 3738 I
122 13 M 5 STUDENT H FIELD RF 30 A 19:00 10 5 1:00 A A A A A A A A A A A A A A A A A A A A A A A P A A P P P A A 24 200 NIL 120 6360 I
123 35 M 2 WEAVER H HOME LH 3 A 10:30 15 2 3:00 A A A A A A A A A A A A A A A A A A A A A A A A A A A A P A A 26 100 90 90 7434 I
124 30 M 3 DRIVER H FIELD LF 9 A 17:00 10 3 9:00 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A P 114 400 200 410 5616 I
125 30 M 4 F H FIELD LF 18 A 18:00 10 4 22:30 A A A A A A A A A A A A A A A A A A A A A A A P P A A A A A A 14 100 100 250 5988 I
126 60 F 5 F H FIELD LL 12 A 8:00 10 5 10:45 A A A A A A A A A A A A A A A A A A A P A A A P A A A A P A A NIL 150 40 140 6360 I
127 35 F 6 F H FIELD RF 10 A 19:30 10 6 5:50 A P A A A A A A A A A A A A A A A P A P A A P P P P A A P A P 100 300 60 100 6732 I
128 60 F 6 F H FIELD LH 100 A 13:00 5 6 21:00 A A A A A A A A A A A A A A A A A A A A A A P P A A A P A A 500 20 60 160 4482 I
129 13 M 6 STUDENT H FIELD RL 50 A 11:30 18 6 1:00 A A A A A A A A A A A A A A A A A A A A A A A P P A P P P A P 1200 500 NIL 200 8100 I
